Chad vs Mongolia: HIV-positive TB patients on ART (antiretroviral therapy)
Chad
100.0%
in 2024
Mongolia
100.0%
in 2024
Chad rank
1st
Mongolia rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Chad
- Mongolia
How they compare
Chad currently reports 100.0% against 100.0% in Mongolia, a difference of 0.0%.
The two have swapped places 4 times across 13 shared years of data; in 2010 it was Mongolia ahead.
Chad ranks 1st and Mongolia ranks 1st of 144 countries.
Mongolia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Chad | Mongolia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 61.1% | 75.7% | 14.6% | Mongolia |
| 2020s | 99.5% | 100.0% | 0.5% | Mongolia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Chad or Mongolia?
- Chad, at 100.0% against 100.0% in Mongolia as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Chad and Mongolia?
- 0.0%, with Chad ahead.
- How many years of comparable data are there for Chad and Mongolia?
- 13 years are reported by both, from 2010 to 2024.
- How do Chad and Mongolia rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Chad ranks 1st and Mongolia ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.